Cargando…
MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
BACKGROUND: Melanoma cells are usually characterized by a strong proliferative potential and efficient invasive migration. Among the multiple molecular changes that are recorded during progression of this disease, aberrant activation of receptor tyrosine kinases (RTK) is often observed. Activation o...
Autores principales: | Meierjohann, Svenja, Hufnagel, Anita, Wende, Elisabeth, Kleinschmidt, Markus A, Wolf, Katarina, Friedl, Peter, Gaubatz, Stefan, Schartl, Manfred |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915980/ https://www.ncbi.nlm.nih.gov/pubmed/20667128 http://dx.doi.org/10.1186/1476-4598-9-201 |
Ejemplares similares
-
The MAPK pathway as an apoptosis enhancer in melanoma
por: Haydn, Johannes M., et al.
Publicado: (2014) -
NRF2 Enables EGFR Signaling in Melanoma Cells
por: Kreß, Julia Katharina Charlotte, et al.
Publicado: (2021) -
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
por: Leikam, C, et al.
Publicado: (2015) -
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
por: Grimm, Johannes, et al.
Publicado: (2018) -
Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins
por: Teutschbein, Janka, et al.
Publicado: (2010)